Receipt: date: 04/18/2017
`
`15/323,901 .. GAE}: 1798
`
`PTOISBI'DBa (03-15)
`Doc code' IDS
`Approved for use through 071311'2016. OMB 0651-0031
`.
`.
`.
`_
`'.
`.
`us. Patent and Trademark Office; U_s. DEPARTMENT OF COMMERCE
`Doc description. Information Disclosure Statement (IDS) FIIed
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Number
`Filing Date
`
`First Named Inventor
`
`
`| 5323001
`
`
`I 1
`
`
`
`
`
`799
`Art Unit
`
`
`
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`I 096534-0014
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /JN/
`
`
`
`
`U.S.PATENTS -
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code1 Issue Date
`
`Name of Patentee or Applicant
`of cited Document
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`
`
`
`If you wish to add additional US. Patent citation information please click the Add button. Add
`U.S.PATENT APPLICATION PUBLICATIONS -
`
`Kind
`Publication
`
`
`
`Name of Patentee or Applicant
`Code1 Date
`of cited Document
`
`
`
`
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`Examiner Cite No Publication
`Initial*
`Number
`
`
`
`
`_
`
` -—
`
`Examiner Cite Foreign Document
`Initial*
`No
`Number3
`
`
`' 012l164552
`
`012143204
`011-196849
`
`|
`|
`
`1
`
`
`
`2
`3
`
`
`
`EFS Web 2.1.17
`
`Country
`Code2i
`
`Kind
`Publication
`Code4 Date
`
`Name of Patentee or
`ApplIcant Of c'ted
`Document
`
`adisens Diagnostics Ltd
`
`Pages,Columns,Lines
`where Relevant
`Passages or Relevant
`Figures Appear
`
`
`
`
`myCOVP-
`_,
`
`E‘E'Zsh‘lg‘éié‘éssI
`
`X
`
`with English abstract.
`
`E
`
`

`

`
`iii/323,001 m GAE}: 1198
`Remipi; date; 04]}.34’2017
`
`Application Number
`15323001
`
`
`Filing Date
`2016-12-29
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`First Named Inventor Masayuki SAIKI
`
`Art Unit
`| 1799
`Examiner Name
`Not Yet Assigned
`I 096534-0014
`
`
`
`ALL
`
`
`
`—l N
`
`—l 00
`
`4:.
`
`EFS Web 2.1.17
`
` Attorney Docket Number
`
`
`
`REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/JN/
`
`oo5”o A 1:U1LoU‘I
`
`oo‘P A onocococo
`
`OO'7"Dis] _\ U1U1-...1
`
`‘
`
`‘
`
`‘
`
`‘
`
`2009—08—1 3
`
`2007—03—22
`
`ooco'_\
`
`1.9on1::
`
`2008—07—1 7
`
`I
`
`l'
`
`0': —I
`
`N0':4:.[\Jan1.9
`
`1986—1 1—22
`
`-007778
`
`2011—01—13
`
`vuvvDonOOO3O—|ggdd
`
`-502793
`
`CD
`
`34;§
`
`v
`
`C _| 'T’M _\ U'l01 a U1
`
`2001—02—27
`
`3
`
`1 998—04—02
`
`2006—03—1 6
`
`2012—11
`
`_08
`
`<5 —I ‘1"D84:.DOU‘I
`
`2013—03—14
`
`2006—01—12
`
`anon KK
`
`corresponds to
`US 200510287577.
`
`
`
`'anasonic Co
`
`rp.
`
`corresponds to
`US 201010221741.
`
`with English abstract.
`
`US 200810156079.
`
`ui an Jean
`9
`
`corresponds to
`us 4,673,653.
`
`corresponds to
`Hoffmann—la Roche AG US 201110124128.
`
`corresponds to
`WO 98113684.
`
` corresponds to
`
`dvance Co., Ltd.
`
`with English abstract.
`
`corresponds to
`US 201210244607.
`
`Ohm 0° Ltd
`
`corresponds to
`us 201310029361.
`
`
`
`

`

`
`Remipi; date; GIL/131%?
`15/323,0Q1 w GM: 1198
`
`Application Number
`15323001
`
`
`Filing Date
`2016-12-29
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`First Named Inventor Masayuki SAIKI
`Art Unit
`| 1799
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`l096534-0014
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH. fJN/i
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`NON-PATENT LITERATURE DOCUMENTS
`
`Add
`
`
`
`
`
`
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`Examiner Cite
`T5
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`
`publisher, city and/or country where published.
`
`
`
`
`
`
`If you wish to add additional non-patent literature document citation information please click the Add button
`
`EXAMINER SIGNATURE
`
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`
`
`EFS Web 2.1.17
`
`

`

`
`Remipi; dais; GMWZQl'?
`15/323,0Q1 w GM: 1198
`
`Application Number
`15323001
`
`
`Filing Date
`2016-12-29
`
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`First Named Inventor Masayuki SAIKI
`Art Unit
`| 1799
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`I 096534-0014
`
`
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`El
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`X A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`
` NamelPrint
`Signature
`2017—04—18
`
`
`
`

`

`Receipt date: 04/18/2017
`
`iii/323,901 .. GAE}: 1798
`
`Privacy Act Statement
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process andr'or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record 5.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`
`
`
`
`EFS Web 2.1.17
`
`